In about 70 percent of all clinical decisions, in-vitro diagnostics (IVD) is a very important healthcare resource not only for disease detection but also for monitoring a patient's condition, deciding the line of treatment, seeing that the treatment is complete, or to decide whether there is a cure, or for prognosis.
In India, the laboratory and diagnostic business is at a crucial juncture, as it is changing from a profit-driven area to a customer-centric stream, and is in the course of becoming the soul of the healthcare sector, given the rising need of early detection and monitoring demanded today by several life-threatening diseases.
In recent times, there has been plenty of advances in the IVD space, whether at the genomics, the molecular diagnostics, the technology, instrumentation, materials used, or the software solution levels. The Covid-19 pandemic accelerated this advancement. The global in-vitro diagnostics (IVD) market size is projected to reach $96.0 billion by 2025 from $84.5 billion in 2020, according to a ResearchAnd Markets report. According to the same research firm, the India IVD (Instruments & Reagents) market is likely to reach $1.8 billion mark by 2025.
The emerging technologies
Thanks to the demands of the Covid era, polymerase chain reaction (PCR) testing has become mainstream with its ability to quickly churn out results using the same sample for multiple detections, informs Chandrashekhar Nair, Co-Founder and CTO, Molbio Diagnostics.
This story is from the January 2023 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the January 2023 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
ADDRESSING INDIA'S RURAL CARE GAP
Lakhs of rural Indians lack access to healthcare services. Learn the ways India can improve healthcare accessibility in its rural areas.
iMeUsWe unveils at-home DNA testing services
iMeUsWe and MapMyGenome's at-home DNA testing to offer health and ancestry insights.
CAR T-CELL THERAPY: A PROMISING CANCER TREATMENT ADVANCEMENT
Employing genetically modified immune cells to attack tumors, CAR T-cell therapy offers new hope for cancer patients.
LEADING WITH INNOVATION
\"Every regional market presents a unique set of challenges and opportunities,\" said Ms Zahabiya Khorakiwala, Managing Director, Wockhardt Hospitals Group, during Healthcare Radius Leadership Vidcast.
OVERCOMING INDIA'S AMR CHALLENGE
India faces a growing threat of antimicrobial resistance (AMR). Experts warn of superbugs and ineffective treatments. Is there hope? Read on to find out.
SOCC launches online second opinion for pediatric care
SOCC’s online second opinion consultations for pediatric care aims to bridge the gap in pediatric healthcare services in India.
Clove Dental opens 12 clinics in a single day
Clove Dental marks its 13th anniversary with nationwide expansion. Get full details.
BM Birla Heart Hospital launches cardiac care program
BM Birla Heart Hospital partners with Dozee for Al-powered cardiac care program.
PD Hinduja Hospital goes digital for infection control
Ropes in Ibhar Technologies for infection control, patient safety, and auditing automation.
Maruti Suzuki marks one year of cardiac care in rural Gujarat
Maruti Suzuki celebrates one year of providing advanced cardiac care in rural Gujarat.